Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Avanos Medical, Inc. AVNS
$22.80
-$0.32 (-1.38%)
На 18:01, 12 мая 2023
+18.42%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
1074503070.00000000
-
week52high
31.99
-
week52low
19.32
-
Revenue
820000000
-
P/E TTM
22
-
Beta
0.92941100
-
EPS
1.04000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 11:00
Описание компании
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Keybanc | Overweight | Overweight | 10 авг 2022 г. |
| Stifel | Hold | Hold | 18 июл 2022 г. |
| Morgan Stanley | Underweight | Underweight | 15 июл 2022 г. |
| Morgan Stanley | Underweight | Underweight | 05 мая 2022 г. |
| Keybanc | Overweight | Overweight | 24 февр 2022 г. |
| Morgan Stanley | Underweight | Underweight | 11 окт 2022 г. |
| Keybanc | Overweight | Overweight | 03 ноя 2022 г. |
| Morgan Stanley | Underweight | Underweight | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| OLEARY PATRICK J | A | 46262 | 7008 | 03 янв 2023 г. |
| Shimer Julie Ann | A | 41212 | 7008 | 03 янв 2023 г. |
| BLACKFORD GARY | A | 51212 | 7008 | 03 янв 2023 г. |
| BYRNES JOHN P | A | 41240 | 7008 | 03 янв 2023 г. |
| Greiner Michael | D | 93765 | 4726 | 03 янв 2023 г. |
| Holbrook Kerr | D | 32105 | 615 | 07 ноя 2022 г. |
| Hurley John Joseph | D | 3931 | 474 | 31 окт 2022 г. |
| Ball David Edward | D | 10636 | 599 | 06 сент 2022 г. |
| Ball David Edward | D | 11235 | 733 | 06 сент 2022 г. |
| Ball David Edward | D | 11968 | 2015 | 06 сент 2022 г. |
Новостная лента
Avanos (AVNS) Q1 Earnings and Revenues Fall Shy of Estimates
Zacks Investment Research
05 мая 2023 г. в 15:57
Despite strength in Avanos' (AVNS) Chronic Care segment, its overall first-quarter results reflect soft performances.
Avanos Medical (AVNS) Q1 Earnings and Revenues Lag Estimates
Zacks Investment Research
03 мая 2023 г. в 09:55
Avanos Medical (AVNS) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.26 per share a year ago.
Avanos Medical: Cost Restructuring Could Unlock Substantial Value
Seeking Alpha
21 апр 2023 г. в 05:16
Avanos Medical: Cost Restructuring Could Unlock Substantial Value.
Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
Zacks Investment Research
13 апр 2023 г. в 11:25
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BRKR's Canopy Biosciences Partners With Enable Medicine
Zacks Investment Research
13 апр 2023 г. в 09:08
BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.